PSA Velocity Threshold is Too High
ORLANDO—New findings presented here suggest clinicians should use a lower PSA velocity (PSAV) to recommend prostate biopsies in men who have PSA levels less than 4 ng/mL.
ORLANDO—New findings presented here suggest clinicians should use a lower PSA velocity (PSAV) to recommend prostate biopsies in men who have PSA levels less than 4 ng/mL.
In the PSA era, most men with newly diagnosed prostate cancer present with clinically localized disease and are curable with surgery or radiation.
ORLANDO—Intensity-modulated radiation therapy (IMRT) may offer a promising salvage option for prostate cancer patients who experience PSA relapse following radical prostatectomy, researchers said.
Biennial PSA screening decreases the likelihood of being diagnosed with metastatic prostate cancer, but nearly doubles the chance of being diagnosed with prostate cancer of any type, a Swedish sudy found.
Preoperative PSA velocity is more useful than PSA doubling time for predicting outcomes after radical prostatectomy for prostate cancer, according to researchers.
Diagnostic PSA levels in men younger than 50 years are significantly lower than guidelines suggest, according to researchers.
As little as 1 mg/day of finasteride can seriously distort the results of a PSA screening for prostate cancer, a recent study has found.
African-American (AA) men with nonpalpable prostate cancer have greater cancer volumes and higher prostatectomy Gleason scores than white men with similar PSA levels at the time of biopsy, according to a study.
PSA levels and PSA doubling time (PSADT) prior to radiotherapy predict outcomes following rescue radiation therapy for men with prostate cancer.